Payer+Provider's Health System Review
May 9, 2020
Gilead Sciences committed to supplying approximately 607,000 vials over the next six weeks to treat an estimated 78,000 hospitalized patients.
May 8, 2020
One promising candidate is remdesivir, a drug originally developed for Ebola, which the FDA has approved for emergency use during the pandemic.
Insurers get a one week extension to finalize 2021 exchange plan applications, giving them time to analyze the effect of COVID-19 in setting premiums.
May 7, 2020
Patient and staff morale has improved following implementation of a personalized, virtual rounding program intended to foster connectedness.
AHIP and HFMA expect to issue voluntary billing guidance for outpatient services soon.
May 6, 2020
Consumer-centric digital services could become the new norm, according to CEO and President Larry Merlo.
The results aim to act as a "playbook" of sorts for leaders and administrators who are looking for better ways to keep their group properly trained.